Organophosphorous indazole derivatives and use thereof as protein kinase inhibitors

Details for Australian Patent Application No. 2004299299 (hide)

Owner Aventis Pharma S.A.

Inventors Clerc, Francois; Commercon, Alain; Cherrier, Marie-Pierre; Filoche-Romme, Bruno; Mailliet, Patrick; Minoux, Herve

Agent Davies Collison Cave

Pub. Number AU-A-2004299299

PCT Pub. Number WO2005/058923

Priority 0314778 17.12.03 FR

Filing date 15 December 2004

Wipo publication date 30 June 2005

International Classifications

C07F 9/38 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/44 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/058923 Priority application(s): WO2005/058923

7 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004299305-Sized glass fibres with fast impregnation for the reinforcement of polymer materials

2004299296-Retaining device of a tool cotter for a percussive demolition apparatus